4,746
Views
13
CrossRef citations to date
0
Altmetric
Review

From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection

, , , , , , & show all
Pages 1431-1446 | Received 04 Jul 2021, Accepted 13 Aug 2021, Published online: 15 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Thalia Pacheco-Fernandez, Hannah Markle, Chaitenya Verma, Ryan Huston, Sreenivas Gannavaram, Hira L Nakhasi & Abhay R Satoskar. (2023) Field-Deployable Treatments For Leishmaniasis: Intrinsic Challenges, Recent Developments and Next Steps. Research and Reports in Tropical Medicine 14, pages 61-85.
Read now
Mariana Verdan, Igor Taveira, Flávia Lima, Fernanda Abreu & Dirlei Nico. (2023) Drugs and nanoformulations for the management of Leishmania infection: a patent and literature review (2015-2022). Expert Opinion on Therapeutic Patents 33:3, pages 137-150.
Read now
Paul M. Kaye, Sakshi Mohan, Carsten Mantel, Melissa Malhame, Paul Revill, Epke Le Rutte, Vivak Parkash, Alison M. Layton, Charles J.N. Lacey & Stefano Malvolti. (2021) Overcoming roadblocks in the development of vaccines for leishmaniasis. Expert Review of Vaccines 20:11, pages 1419-1430.
Read now

Articles from other publishers (10)

Esther Camacho, Sandra González-de la Fuente, Jose Carlos Solana, Laura Tabera, Fernando Carrasco-Ramiro, Begoña Aguado & Jose M. Requena. (2023) Leishmania infantum (JPCM5) Transcriptome, Gene Models and Resources for an Active Curation of Gene Annotations. Genes 14:4, pages 866.
Crossref
Mariana Diupotex, Jaime Zamora-Chimal, Rocely Buenaventura Cervantes-Sarabia, Norma Salaiza-Suazo & Ingeborg Becker. (2023) Alpha-galactosylceramide as adjuvant induces protective cell-mediated immunity against Leishmania mexicana infection in vaccinated BALB/c mice. Cellular Immunology 386, pages 104692.
Crossref
Chinyere A. Knight, David R. Harris, Shifaa O. Alshammari, Ayele Gugssa, Todd Young & Clarence M. Lee. (2023) Leishmaniasis: Recent epidemiological studies in the Middle East. Frontiers in Microbiology 13.
Crossref
Paul M. Kaye, Vivak Parkash, Alison M. Layton & Charles J. N. Lacey. 2023. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges 263 279 .
Rasit Dinc. (2022) Leishmania Vaccines: the Current Situation with Its Promising Aspect for the Future. The Korean Journal of Parasitology 60:6, pages 379-391.
Crossref
Kayla Paulini, Patrick Lypaczewski, Wen-Wei Zhang, Dilhan J. Perera, Momar Ndao & Greg Matlashewski. (2022) Investigating the Leishmania donovani sacp Gene and Its Role in Macrophage Infection and Survival in Mice. Tropical Medicine and Infectious Disease 7:11, pages 384.
Crossref
Farhad Ali Khattak, Taj Ali Khan, Mubashir Hussain, Shahid Niaz Khan, Naeem Ullah, Basheer Rehman, Muhammad Qasim, Aziz Ur Rehman Safi, Muhammad Ishfaq & Saima Afaq. (2022) Analysis of associated risk factors among recurrent cutaneous leishmaniasis patients: A cross-sectional study in Khyber Pakhtunkhwa, Pakistan. Journal of Infection and Public Health 15:11, pages 1175-1179.
Crossref
Jose Carlos Solana, Carmen Chicharro, Emilia García, Begoña Aguado, Javier Moreno & Jose M. Requena. (2022) Assembly of a Large Collection of Maxicircle Sequences and Their Usefulness for Leishmania Taxonomy and Strain Typing. Genes 13:6, pages 1070.
Crossref
Greta Volpedo, Parna Bhattacharya, Sreenivas Gannavaram, Thalia Pacheco-Fernandez, Timur Oljuskin, Ranadhir Dey, Abhay R. Satoskar & Hira L. Nakhasi. (2022) The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates. Pathogens 11:4, pages 431.
Crossref
Hadida Yasmin, Anureeta Adhikary, Mohammed N. Al-Ahdal, Syamal Roy & Uday Kishore. (2022) Host–Pathogen Interaction in Leishmaniasis: Immune Response and Vaccination Strategies. Immuno 2:1, pages 218-254.
Crossref